Market Overview

Lightning Round: Jim Cramer Weighs In On Bristol-Myers Squibb, Mazor Robotics And More

Related BMY
The Week Ahead In Biotech: Earnings, PDUFA Dates And More
An Eventful February Took Its Toll On TD Ameritrade's Investor Index
BMY SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action ... (GuruFocus)
Vetr Crowd Splits With Analysts, Upgrades Mazor Robotics
25 Stocks Moving In Monday's Pre-Market Session
The Vetr community has upgraded $MZOR to 4.5-Stars. (Vetr)

Jim Cramer spoke on CNBC's "Mad Money Lightning Round" about Bristol-Myers Squibb Co (NYSE: BMY). He said the stock came back and made a new high despite losing a bunch head-to-heads against Keytruda. He likes the stock.

Cramer advised his viewer to hold Mazor Robotics Ltd - ADR (NASDAQ: MZOR) because it's going to be the next Intuitive Surgical, Inc. (NASDAQ: ISRG). He added that problems the company had with Israeli government have passed.

Himax Technologies, Inc. (ADR) (NASDAQ: HIMX) is a speculative stock, thinks Cramer.

Iridium Communications Inc (NASDAQ: IRDM) had a good comeback, but Cramer doesn't see anything that should have driven the stock up so much.

Cramer likes Zagg Inc (NASDAQ: ZAGG) and he thinks there's a lot to the company. He also likes devices that give us more battery life.

Cramer also likes McCormick & Company (NYSE: MKC). He likes its recent acquisition.

Posted-In: CNBC mad money Lightning Round Jim CramerMedia


Related Articles (HIMX + BMY)

View Comments and Join the Discussion!